Learn · Peptides

KPV, explained

Three amino acids from the tail of a hormone the body already makes. What cell and animal research on inflammatory signaling has explored, and how much is still unknown.

KPV is one of the smallest peptides in research use — just three amino acids — and it is a fragment of a hormone the body already makes. It has been studied almost entirely in cells and animals, in the context of inflammation. This guide explains what KPV is, what that research has explored, and how much is still unknown.

What KPV is

KPV takes its name from the one-letter codes for its three amino acids: lysine (K), proline (P) and valine (V). Together they form the tail end of alpha-melanocyte-stimulating hormone, or α-MSH — a signaling molecule in the melanocortin system, the family of hormones and receptors involved in, among other things, skin pigmentation and appetite.

Researchers became interested in the fragment because α-MSH has well-documented effects on inflammatory signaling, and experiments suggested that this three-amino-acid tail keeps some of that activity without the hormone's effect on pigmentation.

What researchers have studied

In cell-culture experiments, KPV has been examined for its effect on NF-κB, a molecular switch that turns on inflammatory genes, and on the signaling proteins those genes produce. In animal models, it has been studied most in the intestine and in the skin. Some of that work found that intestinal cells can take the peptide up through a transporter that normally absorbs fragments of digested protein.

These are observations about how the peptide behaves in experimental systems. They are hypotheses about mechanism, not demonstrations of a benefit in people.

Where the evidence stops

Human research on KPV is minimal. There are no large, controlled clinical trials establishing that it is safe or effective for any condition, and its long-term safety has not been characterized. A change in an inflammatory marker in a dish or in a mouse is not evidence of a benefit for a person.

What a prescribed protocol looks like

The form, the amount, the schedule and the duration of any protocol are decisions made by the prescribing provider for the individual patient. Nothing in this article should be read as a dosing recommendation. If a source online offers you KPV without a licensed provider and a real evaluation involved, treat that as a warning sign, not a shortcut.

FDA status and compounding: what to know

The regulatory picture here deserves precision. KPV is not an FDA-approved medication: no product containing it has been approved by the FDA for any use. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety or efficacy.

In July 2026, an FDA advisory committee reviewed whether KPV should be added to the list of substances that pharmacies may use in compounding. That review concerns what licensed pharmacies may prepare on a valid prescription. It is not an FDA approval, and it does not establish that KPV is safe or effective for any use.

KPV is not yet available through Peptivik. If and when it is offered, it will be by prescription only, after an evaluation by a licensed provider, and prepared for individual patients by state-licensed US compounding pharmacies — a different regulatory lane than FDA premarket review, and one you should expect any honest platform to disclose plainly.

If you compete in a tested sport

Anti-doping rules restrict a number of peptides, including substances that have no regulatory approval. If you are subject to drug testing, check your sport's current prohibited list before considering KPV.

Questions worth asking a provider

  • What the human evidence does and does not show for the reason you are considering it.
  • Whether there is an established, approved treatment for your situation that should be considered first.
  • What is known, and what is not known, about side effects and long-term safety.
  • What they would want to evaluate first, and what would lead them to advise against it.

The bottom line

KPV is a three-amino-acid fragment of a hormone the body makes, studied in cells and animals for its effects on inflammatory signaling. Human research is minimal, and it is not FDA-approved for any use. Whether it is appropriate for you is a decision that belongs with a licensed provider who can weigh that limited evidence against your health history.

This content is educational and not a substitute for advice from your provider.

← All guides